Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0-B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study

Feng Xiaobin; Xu Ruocai; Du Xilin; Dou Kefeng; Qin Xiao; Xu Jun; Jia Weidong; Wang Zhiming; Zhao Hongzhi; Yang Shufa; Guo Chenyang; Liu Tianqi; Ma Kuansheng

首页> 外文期刊>The American Journal of Gastroenterology >Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0-B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study

【24h】

Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0-B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study

机译：索拉非尼联合射频消融治疗BCLC 0-B1期肝细胞癌：多中心回顾性队列研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVES: The objective of this study was to evaluate the efficacy of combined therapy using Sorafenib and radiofrequency ablation (RFA) with curative intent for all detectable lesions in patients with Barcelona Clinic Liver Cancer (BCLC) Stage 0-B1 hepatocellular carcinoma (HCC).

机译：目的：本研究的目的是评估在患有巴塞罗那临床肝癌（BCLC）0-B1期肝细胞癌（HCC）的所有可检测病变中采用索拉非尼和射频消融（RFA）联合治疗的疗效。

著录项

来源
《The American Journal of Gastroenterology》 |2014年第12期|共9页
作者
Feng Xiaobin; Xu Ruocai; Du Xilin; Dou Kefeng; Qin Xiao; Xu Jun; Jia Weidong; Wang Zhiming; Zhao Hongzhi; Yang Shufa; Guo Chenyang; Liu Tianqi; Ma Kuansheng;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0-B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study [J] . Feng Xiaobin, Xu Ruocai, Du Xilin, The American Journal of Gastroenterology . 2014,第12期

机译：索拉非尼联合射频消融治疗BCLC 0-B1期肝细胞癌：多中心回顾性队列研究
2. Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0-B1 Hepatocellular Carcinoma [J] . Yang Tian, Zhang Han, Shen Yi-Nan, The American Journal of Gastroenterology . 2015,第4期

机译：索拉非尼联合射频消融治疗BCLC 0-B1期肝细胞癌
3. The efficacy of radiofrequency ablation combined with transcatheter hepatic chemoembolization for patients with BCLC stage B hepatocellular carcinoma: A multicenter retrospective study-propensity score matching [J] . Hirooka Masashi, Hiraoka Atsushi, Ochi Hironori, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：射频消融联合经截面肝化疗栓塞对BCLC阶段B肝细胞癌患者的疗效：多中心回顾性研究 - 倾销分数匹配
4. Molecular Therapies in Hepatocellular Carcinoma beyond Sorafenib: Lessons from Failed Phase III Trials and Novel Targets [C] . Lipika Goyal, Andrew X. Zhu Gastrointestinal Cancers Symposium . 2014

机译：Sorafenib之外的肝细胞癌中的分子疗法：III期试验失败的课程和新型靶标
5. Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Sch?nlein purpura nephritis: a multicenter retrospective cohort study [D] . Inagaki Koji, 稲垣浩司 2019

机译：成人牛Henoch-Sch？nlein紫癜性肾炎根据牛津分类对毛细血管内膜增生的临床影响：一项多中心回顾性队列研究
6. Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan [O] . Hiroki Nishikawa, Haruhiko Takeda, Kaoru Tsuchiya, 2014

机译：索拉非尼治疗BCLC B / C期肝细胞癌；老年患者的临床结果和安全性：日本的一项多中心研究
7. Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan [O] . Hiroki Nishikawa, Haruhiko Takeda, Kaoru Tsuchiya, 2014

机译：Sorafenib治疗BCLC阶段B / C肝细胞癌;老年患者的临床结果和安全性：日本的多中心研究

Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0-B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study

摘要

著录项

相似文献

相关主题

期刊订阅